Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Was Esha Gupta Hardik Pandya's dream girl? The bold queen said- we were on a dating stage...
Along with Hardik Pandya's cricket career, his fans are also impatient to know about his love lif
Indian opener KL Rahul scored his 11th century in his Test career against the West Indies. He sco
Anyone who heard about the Nikki murder case in the Greater Noida (Gautam Buddha Nagar) district
Pushpa 2: A huge mistake happened during the screening of 'Pushpa 2', the audience got angry.
A strange incident was seen regarding 'Pushpa 2' in Kochi. Only the post-interval part of Allu Ar
A surprising incident unfolded during the ILT20 final played at the Dubai International Stadium,
Bollywood actor Sunny Deol is currently in the limelight for his upcoming film 'Jaat'. This film
Prime Minister Narendra Modi, who is on a visit to Croatia, has taken traditional gifts from Odis
If the weather is favorable, the Delhi government may conduct its first test of artificial rain o
For the first time in the history of the Delhi Assembly, two women have occupied the top position
On Wednesday, Pakistan Prime Minister Shehbaz Sharif reiterated that he is ready to hold talks wi
